تحميل...

Dietary DHA supplementation in an APP/PS1 transgenic rat model of AD reduces behavioral and Aβ pathology and modulates Aβ oligomerization

Increased dietary consumption of docosahexaenoic acid (DHA) is associated with decreased risk for Alzheimer’s disease (AD). These effects have been postulated to arise from DHA’s pleiotropic effects on AD pathophysiology, including its effects on β-amyloid (Aβ) production, aggregation, and toxicity....

وصف كامل

محفوظ في:

التفاصيل البيبلوغرافية
الحاوية / القاعدة:	Neurobiol Dis
المؤلفون الرئيسيون:	Teng, Edmond, Taylor, Karen, Bilousova, Tina, Weiland, David, Pham, Thaidan, Zuo, Xiaohong, Yang, Fusheng, Chen, Ping-Ping, Glabe, Charles G., Takacs, Alison, Hoffman, Dennis R., Frautschy, Sally A., Cole, Gregory M.
التنسيق:	Artigo
اللغة:	Inglês
منشور في:	2015
الموضوعات:	Article
الوصول للمادة أونلاين:	https://ncbi.nlm.nih.gov/pmc/articles/PMC4641021/ https://ncbi.nlm.nih.gov/pubmed/26369878 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nbd.2015.09.002
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

Dietary DHA supplementation in an APP/PS1 transgenic rat model of AD reduces behavioral and Aβ pathology and modulates Aβ oligomerization

مواد مشابهة